Tag - vaccines-medicine

 
 

VACCINES MEDICINE

Japan Times
WORLD / Science & Health
Oct 18, 2022
High hopes for nasal COVID-19 vaccines despite 'disappointing' trial
By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that line the nose and mouth.
Japan Times
WORLD / Science & Health
Oct 14, 2022
Scientists find gene variant tied to better COVID shot response
Scientists have identified an immunity gene variant in people with strong responses to COVID-19 vaccines who were less likely to get breakthrough infections.
Japan Times
JAPAN / FOCUS
Oct 7, 2022
What did Japan learn from its largest and deadliest COVID wave?
While the surge of infections — fueled by the BA.5 subvariant of the omicron variant — has subsided, some important questions remain unanswered.
Japan Times
ASIA PACIFIC / Science & Health
Sep 30, 2022
A Chinese mRNA COVID vaccine gets its first approval — in Indonesia
Indonesia's food and drugs agency approved the use of Walvax Biotechnology's mRNA vaccine, which has been in development for more than two years.
Japan Times
JAPAN
Aug 6, 2022
Japan to roll out COVID vaccine that targets omicron as early as October
The new vaccine is under development and was found to increase neutralizing antibodies against the BA.1 subvariant and were also effective for the BA.5 subtype to some extent.
Japan Times
WORLD / Science & Health
May 23, 2022
Drugmakers propose swift pandemic response to benefit poorer countries
The global debate on a better response to disease outbreaks is in full swing as health ministers will meet in Geneva this week for the World Health Organization's assembly.
Japan Times
WORLD / Science & Health
Apr 18, 2022
Is COVID more dangerous than driving? How scientists are parsing COVID-19 risks.
Even two years into the pandemic, the coronavirus remains new enough, and its long-term effects unpredictable enough, that measuring the threat posed by an infection is a thorny problem.
Japan Times
WORLD / Science & Health / FOCUS
Mar 25, 2022
Drugmakers and scientists begin the hunt for long COVID treatments
Leading drugmakers, including those who have launched pills and monoclonal antibodies for COVID-19, are having early discussions with researchers about how to target the disease.
Japan Times
JAPAN / FOCUS
Mar 15, 2022
Japanese firms near domestic rollout of their COVID-19 vaccines
Several companies are expecting to introduce their shots in the coming fiscal year, a major step in Japan reducing its reliance on foreign vaccine manufacturers.
Japan Times
JAPAN
Mar 6, 2022
Shionogi says its COVID-19 shot is effective and safe
The positive data could mean Japan, which is racing to complete a booster drive in hopes of curbing future outbreaks, will soon have an indigenous jab.
Japan Times
ASIA PACIFIC / Science & Health
Feb 19, 2022
These vaccines have been embraced by the world. Why not in China?
Two years into the pandemic, China's 1.4 billion people still don't have access to one of the most effective coronavirus vaccines the world has to offer.
Japan Times
WORLD
Feb 14, 2022
Here’s what the pandemic has in store for the world next
As a virus-weary world limps through the third year of the outbreak, experts warn that omicron won't be the last variant we have to contend with.
Japan Times
WORLD / Science & Health
Feb 1, 2022
How does Merck's COVID-19 pill compare to Pfizer's?
Pfizer said final trial results showed that its treatment reduced the chance of hospitalization or death by 89%, while Merck said their pill reduced those chances by 30%.
Japan Times
WORLD / Science & Health
Jan 16, 2022
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
Japan Times
JAPAN / Science & Health
Dec 29, 2021
Tokyo researchers work toward 'dream' COVID-19 vaccine that gives protection for life
By repurposing the vector used in the long-proven smallpox vaccine, Michinori Kohara hopes to offer more enduring COVID-19 protection against variants that have yet to develop.
Japan Times
BUSINESS
Dec 27, 2021
Tardy COVID-19 vaccine makers under fire for trials in developing nations
Vaccine developers at the testing phase now are seeking developing countries where vaccination rates remain low and the virus is still active.
Japan Times
JAPAN / Science & Health
Dec 24, 2021
Japan government panel approves first oral COVID-19 pill
Clinical trial data shows that patients given the pill within five days of developing symptoms were 30% less likely to be hospitalized or die.
Japan Times
JAPAN
Dec 18, 2021
Japan to shorten booster shot interval for medical workers and seniors on omicron concerns
The interval between second shots and booster shots will be six months for health care workers and those living in nursing homes, the prime minister said.
Japan Times
BUSINESS
Dec 17, 2021
Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
Japan Times
WORLD / Science & Health
Dec 3, 2021
Six vaccines show promise as boosters, led by mRNA shots
Researchers tested the vaccines in more than 2,800 volunteers 30 and older who had already received two doses of the AstraZeneca or Pfizer shots.

Longform

Rows of irises resemble a rice field at the Peter Walker-designed Toyota Municipal Museum of Art.
The 'outsiders' creating some of Japan's greenest spaces